Insider · CIK 0001301120
Randall Moreadith
officer
Files at SER (Serina Therapeutics, Inc.). First filing Jul 2, 2025, latest Mar 24, 2026.
In brief
Randall Moreadith files SEC Form 4 as officer at SER (Serina Therapeutics, Inc.). Since Jul 2, 2025, Randall Moreadith has reported 0 open-market buys worth $0 and 35 open-market sells worth $1.1M, the latest filed on Mar 24, 2026.
A track record needs three past buys with six months of prices behind them; Randall Moreadith has 0, so none is measured yet.
The newest scored trade: sold $19k of SER on Mar 23, 2026, filed Mar 24, 2026, scored 0 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 25 sells worth $501k.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 35
$0 bought, $1.1M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SER: Serina Therapeutics, Inc.
SEROct 9, 2026 · close 2.00
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Serina Therapeutics, Inc. | $19k 6,500 shares | -100% | +146% from low-50% from high | |
| 10Weak | Serina Therapeutics, Inc. | $98k 39,000 shares | -100% | +94% from low-61% from high | |
| 0Weak | Serina Therapeutics, Inc. | $20k 6,500 shares | -100% | +42% from low-57% from high | |
| 0Weak | Serina Therapeutics, Inc. | $23k 6,500 shares | -100% | +42% from low-57% from high | |
| 0Weak | Serina Therapeutics, Inc. | $7,375 2,500 shares | -100% | +55% from low-53% from high | |
| 0Weak | Serina Therapeutics, Inc. | $12k 4,000 shares | -200% | +50% from low-55% from high | |
| 0Weak | Serina Therapeutics, Inc. | $16k 6,500 shares | -120% | +29% from low-61% from high | |
| 6Weak | Serina Therapeutics, Inc. | $35k 13,000 shares | -100% | +37% from low-58% from high | |
| 0Weak | Serina Therapeutics, Inc. | $11k 4,100 shares | -100% | 0% from low-60% from high | |
| 0Weak | Serina Therapeutics, Inc. | $15k 5,673 shares | -100% | 0% from low-58% from high | |
| 0Weak | Serina Therapeutics, Inc. | $9,562 3,227 shares | -100% | 0% from low-54% from high | |
| 0Weak | Serina Therapeutics, Inc. | $5,541 1,700 shares | -100% | 0% from low-51% from high | |
| 0Weak | Serina Therapeutics, Inc. | $12k 3,555 shares | -100% | 0% from low-50% from high | |
| 0Weak | Serina Therapeutics, Inc. | $4,149 1,245 shares | -208% | +2% from low-48% from high | |
| 0Weak | Serina Therapeutics, Inc. | $23k 6,500 shares | -433% | +2% from low-40% from high | |
| 0Weak | Serina Therapeutics, Inc. | $23k 5,965 shares | -50% | +4% from low-38% from high | |
| 0Weak | Serina Therapeutics, Inc. | $2,105 535 shares | -100% | 0% from low-41% from high | |
| 0Weak | Serina Therapeutics, Inc. | $24k 6,500 shares | -100% | 0% from low-40% from high | |
| 5Weak | Serina Therapeutics, Inc. | $27k 6,500 shares | -100% | +2% from low-37% from high | |
| 0Weak | Serina Therapeutics, Inc. | $14k 3,398 shares | -100% | +5% from low-31% from high | |
| 0Weak | Serina Therapeutics, Inc. | $14k 3,102 shares | -100% | +5% from low-33% from high | |
| 5Weak | Serina Therapeutics, Inc. | $28k 5,551 shares | -100% | +24% from low-28% from high | |
| 0Weak | Serina Therapeutics, Inc. | $4,921 949 shares | -100% | +23% from low-29% from high | |
| 5Weak | Serina Therapeutics, Inc. | $32k 6,500 shares | -100% | +18% from low-37% from high | |
| 0Weak | Serina Therapeutics, Inc. | $22k 4,326 shares | -100% | +22% from low-37% from high | |
| 15Weak | Serina Therapeutics, Inc. | $331k 47,674 shares | -2335% | +37% from low-35% from high | |
| 0Weak | Serina Therapeutics, Inc. | $22k 4,304 shares | -193% | +27% from low-39% from high | |
| 5Weak | Serina Therapeutics, Inc. | $29k 5,500 shares | -100% | +33% from low-37% from high | |
| 5Weak | Serina Therapeutics, Inc. | $28k 5,500 shares | -100% | +25% from low-41% from high | |
| 5Weak | Serina Therapeutics, Inc. | $27k 4,196 shares | -100% | +45% from low-31% from high | |
| 26Weak | SERsell Serina Therapeutics, Inc. | $38k 6,500 shares | -100% | +39% from low-34% from high | |
| 26Weak | SERsell Serina Therapeutics, Inc. | $35k 6,500 shares | -100% | +30% from low-38% from high | |
| 26Weak | SERsell Serina Therapeutics, Inc. | $33k 6,500 shares | -100% | +25% from low-40% from high | |
| 6Weak | Serina Therapeutics, Inc. | $37k 6,500 shares | -100% | +35% from low-36% from high | |
| 6Weak | Serina Therapeutics, Inc. | $38k 6,500 shares | -100% | +50% from low-29% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 20, 2026 | SER Serina Therapeutics, Inc. | 91,000 0.85% of outstanding | $279k | Jan 20, 2026 | $396k |
| Oct 14, 2025 | SER Serina Therapeutics, Inc. | 88,826 0.87% of outstanding | $530k | Oct 13, 2025 | $543k |
| Jun 30, 2025 | SER Serina Therapeutics, Inc. | 99,674 1.00% of outstanding | $576k | Jun 30, 2025 | none |
Transactions
The newest 50 of 125 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | SER Serina Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +85,558 | $0.00 | $0 | 85,558 | May 26, 2026 |
| Mar 23, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +6,500 | $0.06 | $390 | 6,500 | Mar 24, 2026 |
| Mar 23, 2026 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,500 | $2.86 | $19k | 0 | Mar 24, 2026 |
| Mar 23, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -6,500 | $0.00 | $0 | 267,686 | Mar 24, 2026 |
| Mar 19, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +39,000 | $0.06 | $2,340 | 39,000 | Mar 20, 2026 |
| Mar 19, 2026 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -39,000 | $2.50 | $98k | 0 | Mar 20, 2026 |
| Mar 19, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -39,000 | $0.00 | $0 | 274,186 | Mar 20, 2026 |
| Feb 3, 2026 | SER Serina Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +69,000 | $0.00 | $0 | 69,000 | Feb 17, 2026 |
| Feb 2, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +6,500 | $0.06 | $390 | 6,500 | Feb 3, 2026 |
| Feb 2, 2026 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,500 | $3.03 | $20k | 0 | Feb 3, 2026 |
| Feb 2, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -6,500 | $0.00 | $0 | 313,186 | Feb 3, 2026 |
| Jan 28, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +6,500 | $0.06 | $390 | 6,500 | Jan 29, 2026 |
| Jan 28, 2026 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,500 | $3.57 | $23k | 0 | Jan 29, 2026 |
| Jan 28, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -6,500 | $0.00 | $0 | 319,686 | Jan 29, 2026 |
| Jan 22, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,500 | $0.06 | $150 | 2,500 | Jan 23, 2026 |
| Jan 22, 2026 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,500 | $2.95 | $7,375 | 0 | Jan 23, 2026 |
| Jan 22, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 326,186 | Jan 23, 2026 |
| Jan 20, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,000 | $0.06 | $120 | 2,000 | Jan 21, 2026 |
| Jan 20, 2026 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,000 | $3.07 | $6,140 | 0 | Jan 21, 2026 |
| Jan 21, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,000 | $0.06 | $120 | 2,000 | Jan 21, 2026 |
| Jan 21, 2026 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,000 | $3.00 | $6,000 | 0 | Jan 21, 2026 |
| Jan 20, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -2,000 | $0.00 | $0 | 330,686 | Jan 21, 2026 |
| Jan 21, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -2,000 | $0.00 | $0 | 328,686 | Jan 21, 2026 |
| Jan 13, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,416 | $0.06 | $325 | 5,416 | Jan 14, 2026 |
| Jan 13, 2026 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,416 | $2.50 | $14k | 0 | Jan 14, 2026 |
| Jan 14, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +1,084 | $0.06 | $65 | 1,084 | Jan 14, 2026 |
| Jan 14, 2026 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,084 | $2.50 | $2,713 | 0 | Jan 14, 2026 |
| Jan 13, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -5,416 | $0.00 | $0 | 333,770 | Jan 14, 2026 |
| Jan 14, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -1,084 | $0.00 | $0 | 332,686 | Jan 14, 2026 |
| Jan 8, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +13,000 | $0.06 | $780 | 13,000 | Jan 9, 2026 |
| Jan 8, 2026 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -13,000 | $2.69 | $35k | 0 | Jan 9, 2026 |
| Jan 8, 2026 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -13,000 | $0.00 | $0 | 339,186 | Jan 9, 2026 |
| Dec 23, 2025 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +4,100 | $0.06 | $246 | 4,100 | Dec 29, 2025 |
| Dec 23, 2025 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,100 | $2.60 | $11k | 0 | Dec 29, 2025 |
| Dec 23, 2025 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -4,100 | $0.00 | $0 | 352,186 | Dec 29, 2025 |
| Dec 22, 2025 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,673 | $0.06 | $340 | 5,673 | Dec 23, 2025 |
| Dec 22, 2025 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,673 | $2.67 | $15k | 0 | Dec 23, 2025 |
| Dec 22, 2025 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -5,673 | $0.00 | $0 | 356,286 | Dec 23, 2025 |
| Dec 16, 2025 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +3,227 | $0.06 | $194 | 3,227 | Dec 17, 2025 |
| Dec 16, 2025 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,227 | $2.96 | $9,562 | 0 | Dec 17, 2025 |
| Dec 16, 2025 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,227 | $0.00 | $0 | 361,959 | Dec 17, 2025 |
| Dec 12, 2025 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +1,700 | $0.06 | $102 | 1,700 | Dec 16, 2025 |
| Dec 12, 2025 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,700 | $3.26 | $5,541 | 0 | Dec 16, 2025 |
| Dec 12, 2025 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -1,700 | $0.00 | $0 | 365,186 | Dec 16, 2025 |
| Dec 11, 2025 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +3,555 | $0.06 | $213 | 3,555 | Dec 12, 2025 |
| Dec 11, 2025 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,555 | $3.24 | $12k | 0 | Dec 12, 2025 |
| Dec 11, 2025 | SER Serina Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,555 | $0.00 | $0 | 366,886 | Dec 12, 2025 |
| Dec 9, 2025 | SER Serina Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +600 | $0.06 | $36 | 600 | Dec 11, 2025 |
| Dec 9, 2025 | SER Serina Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -600 | $3.31 | $1,988 | 0 | Dec 11, 2025 |
| Dec 10, 2025 | SER Serina Therapeutics, Inc. | AGrant or award Common Stock10b5-1 | +645 | $0.06 | $39 | 645 | Dec 11, 2025 |
50 of 125 rows shown.
Questions about Randall Moreadith
Answered from the filings on this page, as of the latest one.
Is Randall Moreadith buying or selling?
In the last 12 months Randall Moreadith reported 0 open-market buys worth $0 and 25 open-market sells worth $501k on SEC Form 4; the latest was sold $19k of SER on Mar 23, 2026. Grants, option exercises and tax withholding are not counted.
How did Randall Moreadith's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Randall Moreadith has 0.
Where does Randall Moreadith file Form 4?
Randall Moreadith has filed Form 4 at SER (Serina Therapeutics, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.